A team of researchers across Canada, including collaborators from Schulich Medicine & Dentistry, is helping to shed light on how our bo
Impact Stories | SARS-COV-2
Filter:
- Climate Change
- Research
- Teaching and Learning
- Operations
- Leadership & Partnership
- Health
- COVID-19
- Mental Health
- Personal Protective Equiment (PPE)
- Global
- Community
- World Health Organization (WHO)
- Vaccine
- Frontline
- National
- Public Health
- Pandemic
- Northern communities
- Volunteers
- International
- Ventilators
- Clinical trials
- Archives
- Social distancing
- Start-up company
- Portable scanner
- AI
- Tests
- Ventilation
- Genetic sequencing
- Mapping
- Remote communities
- First Nations
- Clinical psychology
- Outreach
- Infectious diseases
- Tracing
- Social isolation
- Seniors
- Long-term care
- Engineering
- Surgery
- SARS-COV-2
- Treatment
- Wastewater
- Outbreak
- Science
- Lessons
- Privacy
- Therapeutics
- Agriculture
- Antibodies
- Collaboration
- LGBTQ+
- Study
- Social psychology
- Pediatrics
- Evolution
- Mutation
- Coronavirus
- Black
- Youth
A new variant of coronavirus has swept across the United Kingdom and been detected in the United States, Canada and elsewhere.
A new CHU Sainte-Justine study of the clinical characteristics and disease severity shows that infants who contract the SARS-CoV-2 virus d
Three types of medications approved for other clinical purposes may reduce the inflammatory symptoms caused by the SARS-CoV-2 virus, an Ud
A research team from the CHUM research centre and Héma-Québec has shown how IgM antibodies play a major role in neutralizing the SARS-CoV-
While masks and hand sanitizers have become part of most people's daily arsenal against the coronavirus, McGill r
University of Calgary scientists and clinicians will soon have access to a Biosafety Level 3 (BSL-3) lab to further t
Queen’s University researcher Mona Kanso develops new way of looking at novel coronavirus that could help unco